1 not yet recruiting, 1 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Recruiting 1 |
Follow iBio, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate a Single Dose of IBIO-610 in Participant With Obesity. IBIO-610, Placebo - Obesity & Overweight | Phase 1 | Not yet recruiting | iBio, Inc. | 32 | 2026-12-01 | 2026-10-22 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of IBIO-600 in Overweight or Obese Adults IBIO-600, Placebo - Overweight , Obesity | Phase 1 | Recruiting | iBio, Inc. | 32 | 2026-05-24 | 2026-05-29 |
Obesity (2) · Overweight (2)
Australia (2)
Cory Schwartz, PhD (1) · Molly Carr, MD (1)